Tendon injuries heal via scar tissue rather than regeneration. This healing response forms adhesions between 1 5 the flexor tendons in the hand and surrounding tissues, resulting in impaired range of motion and hand function.
Tendons are dense connective tissues composed primarily of a highly organized type I collagen 0 0 cells have been shown to participate in regenerative tendon healing in neonates, with minimal involvement of 0 1 Scx + cells in mature, scar mediated healing (13), which may account for the lack of phenotype observed in 0 2 EP4cKO Scx . Furthermore, while Scx-lineage cells are observed in the healing tendon ( Figure 6) , we have used a 0 3 non-inducible Scx-Cre, so it is unknown if these Scx-lineage + cells are residual cells from development, or 0 4 newly activated Scx-expressing cells that are involved in healing.
5
Myofibroblasts are believed to be the cellular drivers of fibrotic tendon healing and peritendinous 0 6 adhesions (25, 26), given their ability to produce abundant collagenous ECM. We have used α -SMA expression 0 7
to identify myofibroblasts, consistent with many other studies (27) (28) (29) . However, α -SMA has also been used to 0 8 mark mesenchymal progenitors (30) . While future studies will clarify the lineage, fate and function of these 0 9 cells during tendon healing, there is a consistent demonstration of the involvement of α -SMA + cells during 1 0 tendon healing.
1 1 1 2 While these data clearly identify different cell-type specific functions of EP4 in tendon healing there are 1 3 several limitations that must be considered. We have examined the effects of EP4cKO Scx at only one time-point 1 4
during healing, however, if EP4cKO Scx were to alter healing, our previous data would suggest these effects 1 5
would occur prior to day 14 based on the expression profile of Scx in this healing model (31) . We have also not 1 6
examined the long-term mechanical effects of EP4cKO S100a4 on tendon healing. Finally, while these data 1 7
suggest a role for α -SMA + cell-mediated EP4 induction, and increased scar formation, conditional deletion 1 8 studies of EP4 using an α -SMA-Cre mouse would be required to definitively identify the role of EP4 in α -SMA-1 9 lineage cells.
2 0 2 1
Together with our previous studies using an EP4 systemic antagonist, these data demonstrate cell-type 2 2 specific functions of EP4 in scar-mediated tendon healing. Our data suggest that deletion of EP4 in S100a4-2 3 lineage cells inhibits range of motion-limiting scar tissue without further compromising mechanical properties.
4
However, these beneficial effects of EP4cKO S100a4 are transient, with aberrant up-regulation of EP4 during later 2 5
healing, mediated at least in part by α -SMA + cells, and a subsequent decrease in range of motion. These data 2 6
suggest that sustained inhibition of EP4 in S100a4-lineage cells, and α -SMA-lineage cells may result in 2 7
prolonged improvements in tendon healing. Furthermore, understanding the mechanisms through which EP4 2 8
promotes scar-mediated healing with identify novel therapeutic targets to improve tendon healing. (0.05mg/kg) was administered followed by further analgesia every 12-hours after surgery as needed. Following
9
preparation of the surgical site, the FDL was released at the myotendinous junction in the calf to protect the 5 0 repair site from high strains. The skin was closed with a single 5-0 suture. A 1-2cm incision was then made on 5 1 the posterior surface of the hindpaw, soft tissue was retracted to identify the FDL, and the FDL was completely 5 2 transected using micro-scissors. Following transection the FDL was repaired using 8-0 nylon sutures (Ethicon,
3
Somerville, NJ) in a modified Kessler pattern. The skin was closed with 5-0 suture. The animals were allowed 5 4
unrestricted weight-bearing and movement, and had ad-libitum access to food and water.
6
RNA extraction and qPCR: Total RNA was extracted from healing tendons between 3-28 days post-surgery.
7
RNA was extracted from the repair site and 1-2mm of native tendon on both sides of the repair. RNA was 5 8
extracted from 3 repairs per genotype per time-point. RNA was extracted using TRIzol reagent (Life 5 9
Technologies). 500ng of RNA was used for reverse transcription of cDNA using iScript cDNA synthesis kit 6 0 (Bio-Rad, Hercules, CA). Quantitative PCR (qPCR) was then run using cDNA and gene specific primers 6 1 ( Assessment of Gliding Function: Following sacrifice the hindlimb was removed at the knee, and skin was 8 5
removed down to the ankle. The FDL was isolated at the myotendinous junction and secured using 8 6 cyanoacrylate between two pieces of tape as previously described (31, 35). Briefly, the tibia was secured in an 8 7 alligator clip and the tendon was incrementally loaded with small weights from 0-19g; digital images were ACG TAG ATG AAT TGG GAT GCA G GGG TTG GGG CAG TCT AGT G
AGA TGT GGA TCA GCA AGC AG GCG CAA GTT AGG TTT TGT CA recombination in the tendon we examined healing in the double reporter nT/nG with S100a4-Cre + cells 0 8
expressing GFP, and S100a4-Crecells expressing Td Tomato Red. S100a4-Cre results in recombination in of Rochester for technical assistance with histology and biomechanical testing, respectively.
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